Related Experiment Video
Updated: Jan 4, 2026

10:55
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
2.6K
A negative feedback regulatory loop between miR-138 and TP53 is mediated by USP10
Zhenghua Luo1, Manchao Zhang1, Ri Cui1
1Department of Cancer Biology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Oncotarget
|November 8, 2019
Summary
MicroRNA-138 regulates the tumor suppressor TP53 by targeting USP10. A feedback loop exists where TP53 represses microRNA-138, adding complexity to cancer gene networks.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- TP53 is a crucial tumor suppressor gene, frequently altered in human cancers.
- TP53 expression is tightly regulated by pathways including Mdm2-mediated ubiquitination and deubiquitination by USP7 and USP10.
- MicroRNAs play roles in regulating TP53 levels and function.
Purpose of the Study:
- To investigate the role of microRNA-138 in regulating TP53.
- To elucidate the regulatory mechanism involving microRNA-138, TP53, and USP10.
Main Methods:
- Investigated microRNA-138's direct targeting of USP10.
- Analyzed the feedback loop between TP53 and microRNA-138 expression.
Main Results:
- MicroRNA-138 directly targets and regulates USP10.
- TP53 was found to repress microRNA-138 expression.
- A negative feedback regulatory loop between TP53 and microRNA-138 was identified.
Conclusions:
- MicroRNA-138 acts as a regulator of TP53 by targeting USP10.
- The discovered negative feedback loop adds complexity to the TP53 regulatory network in cancer.
Related Concept Videos
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K

